Atlas Trials

Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex

Clinical trial NCT02932254 · COMPLETED

Trial details

NCT number
NCT02932254
Sponsor
Universidade Federal do Rio de Janeiro
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neuromuscular Blockade
Start date
2016-10-01
Primary completion
2017-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.